Literature DB >> 16709809

Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

Halina Offner1, Sandhya Subramanian, Susan M Parker, Chunhe Wang, Michael E Afentoulis, Anne Lewis, Arthur A Vandenbark, Patricia D Hurn.   

Abstract

Induction of stroke not only produces local ischemia and brain damage, but also has profound effects on peripheral immune responses. In the current study, we evaluated effects on spleen and blood cells 4 days after stroke induction. Surprisingly, there was a less inflammatory cytokine profile in the middle cerebral artery occlusion-affected right brain hemisphere at 96 h compared with earlier time points. Moreover, our results demonstrate that stroke leads to splenic atrophy characterized by a reduction in organ size, a drastic loss of splenocyte numbers, and induction of annexin V+ and TUNEL+ cells within the spleen that are in the late stages of apoptosis. The consequence of this process was to reduce T cell proliferation responses and secretion of inflammatory cytokines, resulting in a state of profound immunosuppression. These changes produced a drastic reduction in B cell numbers in spleen and blood, and a novel increase in CD4+FoxP3+ regulatory T cells. Moreover, we detected a striking increase in the percentage of nonapoptotic CD11b+ VLA-4-negative macrophages/monocytes in blood. Immunosuppression in response to brain injury may account for the reduction of inflammatory factors in the stroke-affected brain, but also potentially could curtail protective immune responses in the periphery. These findings provide new evidence to support the contention that damage to the brain caused by cerebral ischemia provides a powerful negative signal to the peripheral immune system that ultimately induces a drastic state of immunosuppression caused by cell death as well as an increased presence of CD4+FoxP3+ regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709809     DOI: 10.4049/jimmunol.176.11.6523

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  191 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

2.  Ischemic stroke activates hematopoietic bone marrow stem cells.

Authors:  Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

3.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 4.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

5.  Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.

Authors:  Farhaan S Vahidy; Kaushik N Parsha; Mohammad H Rahbar; MinJae Lee; Thanh-Tung Bui; Claude Nguyen; Andrew D Barreto; Arvind B Bambhroliya; Preeti Sahota; Bing Yang; Jaroslaw Aronowski; Sean I Savitz
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

Review 6.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

7.  Splenectomy Does Not Improve Long-Term Outcome After Stroke.

Authors:  Dannielle Zierath; Angela Shen; Astiana Stults; Theresa Olmstead; Kyra J Becker
Journal:  Stroke       Date:  2017-01-13       Impact factor: 7.914

8.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

9.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

Review 10.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.